Initial research is highly concerning that these medications have side effects that need further research before widespread drug administration and adoption, significantly decrease muscle mass, and can cause significant weight gain after stopping
For product liability cases involving medications such as Ozempic, the statute of limitations usually begins when the injury is discovered or should have been discovered
Furthermore, oral formulations may enhance convenience, acceptance, and adherence to GLP-1RA therapy, offering an alternative to facilitate the attainment of glycemic targets, especially in patients hesitant to commence injectable medications [49]
Intermediate Schedule (Prior GLP exposure)
Since they arent approved for weight loss by the FDA, there is no recommended dose to achieve this